Massive study tests if Real-World data can replace clinical trials for diabetes heart risk
NCT ID NCT07203677
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study looked at whether real-world data can reliably compare two diabetes drugs—tirzepatide and sitagliptin—for preventing heart attacks, strokes, or death in people with type 2 diabetes and heart disease. Researchers analyzed records from over 49,000 patients to see if this approach matches results from traditional clinical trials. The goal was to learn when real-world data can be trusted for making treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.